Device Trial Radar · NCT04987138
Safety and Effectiveness Study of the Zenflow Spring System
Last checked: Nov 19, 2026Latest source record: Apr 11, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
279
Planned (sponsor's estimate)
Start
Sep 30, 2021
Primary completion
Jun 30, 2024
Study completion Jun 2026
Sponsor
- Lead sponsor
- Zenflow, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 3, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Male only, from 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Evaluate the safety and effectiveness of the Zenflow Spring System in relieving LUTS associated with BPH.
Conditions
- BPH (Benign Prostatic Hyperplasia)
- Lower Urinary Tract Symptoms (LUTS)
Interventions
Zenflow Spring SystemDevice
The Zenflow Spring Implant is an electropolished and passivated nickel titanium alloy (nitinol) implant. The implant is constructed from a single wire strand formed into ring elements connected by spine sections. There are four sizes of implants ranging from 16 mm to 24 mm in length and 14 mm to 16 mm in diameter to implant in the subject's prostatic urethra. The implant is placed in the urethra using a custom delivery catheter and cystoscope (Spring Scope). The implant is intended to be permanent but can be removed if necessary.
Sham ProcedureDevice
A18 Fr Foley Catheter is placed into the patient's bladder. To mimic the Treatment Arm procedure, the Foley Catheter balloon will be inflated in the bladder. Once inflated, slight tension will be applied against the subject's bladder neck. While tension is being applied the site staff will follow a script to simulate the Zenflow procedural steps. Additionally, devices will be used to produce mock deployment sounds of the Zenflow procedure. Once complete, the balloon will be deflated and the catheter will be removed, completing the procedure.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety - The need for urinary catheterizationTime frame: Greater than 7 days after procedure
- Safety - Adverse EventsTime frame: Procedure through 12 months
- Effectiveness of the Spring Implant in reducing symptoms of Benign Prostatic Hyperplasia (BPH) as compared to ShamTime frame: Procedure to 3 months
1 more outcomes with a free account
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
American Institute of Research
Los Angeles, California
Northshore University Health System
Glenview, Illinois
Sheldon Freedman, MD, LTD
Las Vegas, Nevada
4 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.